Steven Davidoff Solomon writes for The New York Times, May 10, 2016
Bill Gates’s Foundation Trust and his personal investment fund are locked in a brutal shareholder dispute in Switzerland over the sale of a controlling interest in the Swiss specialty chemicals maker Sika.